Is resveratrol a potential substitute for leuprolide acetate in experimental endometriosis?


TEKIN Y. B. , GÜVEN S., KIRBAS A., KALKAN Y., TUMKAYA L., Guven E. S. G.

EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, vol.184, pp.1-6, 2015 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 184
  • Publication Date: 2015
  • Doi Number: 10.1016/j.ejogrb.2014.10.041
  • Journal Name: EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY
  • Journal Indexes: Science Citation Index Expanded, Scopus
  • Page Numbers: pp.1-6
  • Keywords: Endometriosis, Rat model, Resveratrol, Leuprolide acetate, Treatment, RAT MODEL, REGRESSION, TISSUE, INVASIVENESS, ANGIOGENESIS, INFLAMMATION, INHIBITOR, EXPLANTS, IMMUNE

Abstract

Objective: Resveratrol, a phytoalexin polyphenol, has anti-angiogenic, antioxidant, anti-inflammatory properties. We aimed to compare the anti-inflammatory and anti-angiogenic effects of resveratrol and leuprolide acetate (LA) in an experimental endometriosis model.